Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation.

Peggs, Karl S

Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation. [electronic resource] - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Jan 2011 - 49-57 p. digital

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

1537-6591

10.1093/cid/ciq042 doi


Cytomegalovirus--immunology
Cytomegalovirus Infections--immunology
Humans
Immunotherapy, Adoptive--methods
Interferon-gamma--metabolism
Stem Cell Transplantation
T-Lymphocytes--immunology
Treatment Outcome